New review points to faster, safer vaccine development

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa’s focus on increasing its vaccine manufacturing, and pandemic preparedness.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup